Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065901.pdf
0001104659-22-065901.rtf
0001104659-22-065901.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065902.pdf
0001104659-22-065902.rtf
0001104659-22-065902.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065918.pdf
0001104659-22-065918.rtf
0001104659-22-065918.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065921.pdf
0001104659-22-065921.rtf
0001104659-22-065921.xls
May 27, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-065927.pdf
0001104659-22-065927.rtf
0001104659-22-065927.xls
May 25, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-064710.pdf
0001104659-22-064710.rtf
0001104659-22-064710.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 20, 2022 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
0001104659-22-062988.pdf
0001104659-22-062988.rtf
May 17, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-061928.pdf
0001104659-22-061928.rtf
0001104659-22-061928.xls
May 13, 2022 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
0001104659-22-060363.pdf
0001104659-22-060363.rtf
May 06, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-056748.pdf
0001104659-22-056748.rtf
0001104659-22-056748.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.